We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Current Dosing of Oncology Drugs is Unnecessarily High and Needs Revision, Says Report
Current Dosing of Oncology Drugs is Unnecessarily High and Needs Revision, Says Report
Using outmoded dosing structures, oncologists may be giving patients unnecessarily high doses of cancer meds, which provides no added benefit to the patient and, in fact, causes unnecessary side effects. The answer? More trials in oncology.